Table 1.
Definitions of comorbidities and abnormal values for cardiometabolic variables.
| Variable | Age group, yr | Number of subjects evaluated | Definition of comorbidity or abnormal value |
|---|---|---|---|
| Total cholesterol | 5-17 | 7211 | ≥200 mg/dL |
| LDL cholesterol | 5-17 | 7211 | ≥130 mg/dL |
| HDL cholesterol | 5-17 | 7211 | ≤35 mg/dL |
| Triglycerides | 5-17 | 7211 | ≥150 mg/dL |
| ALT | 5-17 | 6869 | >25 U/L (boys) >22 U/L (girls) |
| Prediabetes | 5-17 | 7211 | ≥2 FPG tests 100-125 mg/dL or ≥1 HbA1c test 5.7%-6.4% |
| Diabetes mellitus | 5-17 | 7211 | Inclusion in MHS diabetes registry |
| Systolic BP | 5-12 | 1226 | ≥95th percentile (adjusted to the 50th percentile of age- and gender-specific height) |
| 13-17 | 3773 | ≥130 mm Hg | |
| Diastolic BP | 5-12 | 1226 | ≥95th percentile (adjusted to the 50th percentile of age- and gender-specific height) |
| 13-17 | 3773 | ≥80 mm Hg |
ALT, alanine aminotransferase; BP, blood pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MHS, Maccabi Healthcare Services.